Condition: Prosthetic-joint Infection · Infection Hip · Infection; Knee, Joint · Sponsor: Leiden University Medical Center
In this Dutch multicenter clinical trial, patients with a staphylococcal prosthetic joint infection, will, in the oral antibiotic treatment phase, be randomized between clindamycin monotherapy and rifampicin / levofloxacin combination therapy. The clinical endpoint will be treatment success one year after finishing antimicrobial treatment.
This description comes directly from the study's public registry record.
Henk Scheper, MD · 071-5299239 · h.scheper@lumc.nl
Mark De Boer, MD PhD · 071-5269111 · M.G.J.de_Boer@lumc.nl
Always discuss trial participation with your own doctor first.
| LUMC | Leiden, Zuid Hollans, Netherlands | Recruiting |
| Amsterdam UMC | Amsterdam, Netherlands | Recruiting |
| OLVG | Amsterdam, Netherlands | Recruiting |
| Martini ziekenhuis | Groningen, Netherlands | Not Yet Recruiting |
| UMCG | Groningen, Netherlands | Recruiting |
| Spaarne gasthuis | Hoofddorp, Netherlands | Recruiting |
| Medisch Centrum Leeuwarden | Leeuwarden, Netherlands | Recruiting |
| Alrijne Ziekenhuis | Leiderdorp, Netherlands | Recruiting |
| Radboud UMC | Nijmegen, Netherlands | Recruiting |
| Sint maartenskliniek | Nijmegen, Netherlands | Recruiting |
| Erasmus MC | Rotterdam, Netherlands | Not Yet Recruiting |
| Elisabeth Tweesteden Ziekenhus | Tilburg, Netherlands | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06172010